|
|
Application effect of Diazepam combined with Racemic Anisodamine Hydrochloride in the elimination of cervical edema during the delivery of primipara |
XIE Ting LI Fei LIU Man-ying HUANG Wei-lan CHEN Yin-feng |
Department of Obstetrics and Gynecology, Ganxian People′s Hospital of Ganzhou City, Jiangxi Province, Ganzhou 341100, China |
|
|
Abstract Objective To explore the effect of Diazepam combined with Racemic Anisodamine Hydrochloride in the elimination of cervical edema during the delivery of primipara.Methods A total of 140 primiparas of vaginal trial labor who were admitted to our hospital from January 2017 to January 2020 were selected as the research objects, and were divided into study group (70 cases) and control group (70 cases) according to the random number table method.The study group was given intravenous injection of Diazepam combined with Racemic Anisodamine Hydrochlo, and the control group was given intravenous injection of Diazepam alone.The time from medication to opening of the uterus,total labor stage, postpartum hemorrhage, cesarean section rate, neonatal asphyxia, disappearance rate of cervical edema and adverse reaction rate of the two groups were recorded.Results The time from medication to opening of the uterus in the study group was (188.32±29.83) min, which was shorter than that in the control group of (246.28±30.24)min, the difference was statistically significant (P<0.05).The total labor stage in the study group was (313.62±31.82)min, which was shorter than that in the control group of (372.28±33.28) min, the difference was statistically significant(P<0.05).The postpartum hemorrhage of the study group was (182.37±48.39) ml, less than that in the control group of(233.29±50.28)ml,the difference was statistically significant (P<0.05).The maternal cesarean section rate in the study group was 4.29%, lower than that in the control group (15.71%), the difference was statistically significant (P<0.05).The disappearance rate of maternal cervical edema in the study group was 97.14%, high than that in the control group of 82.86%, the difference was statistically significant (P<0.05).There was no significant difference in the incidence of adverse reactions between the two groups (P>0.05).Conclusion Diazepam combined with Racemic Anisodamine Hydrochloride can effectively eliminate cervical edema in the perinatal period of perinatal women, it could shorten the full opening time of the uterus, shorten the labor process, relieve cervical spasm, reduce postpartum hemorrhage, reduce cesarean section rate, and improve maternal and infant outcomes, worthy of clinical application.
|
|
|
|
|
[1] |
许乾乾,刘荃.地西泮联合缩宫素治疗宫颈水肿的疗效观察[J].临床合理用药杂志,2019,12(4):101-102.
|
[2] |
张艳梅.产科分娩使用盐酸山莨菪碱联合缩宫素的临床护理观察[J].中国保健营养,2017,27(36):379.
|
[3] |
周美华.利多卡因、阿托品和地西泮应用在分娩时宫颈水肿患者治疗中的临床效果研究[J].医药前沿,2017,7(16):155-156.
|
[4] |
黄广翅.间苯三酚联合地西泮对高龄初产妇产程及围生儿结局的影响[J].心理医生,2017,23(19):119-120.
|
[5] |
王爽,祝美洲,黄莘.利多卡因联合阿托品与盐酸山莨菪碱在宫颈韧厚水肿治疗中的临床效果比较[J].中国冶金工业医学杂志,2018,35(1):70-71.
|
[6] |
李君花.地西泮联合间苯三酚在足月妊娠产妇潜伏期的应用效果[J].中国当代医药,2019,26(29):109-111.
|
[7] |
傅小青,孙健.间苯三酚注射液对产程活跃期宫颈水肿产妇的临床效果分析[J].中国现代医生,2018,56(29):68-70.
|
[8] |
王霞.盐酸山莨菪碱注射液用于产程活跃期宫颈水肿的疗效观察[J].中国社区医师(医学 专 业),2011,13(22):134.
|
[9] |
林伟斯.间苯三酚联合地西泮治疗潜伏期宫颈水肿疗效观察[J].现代诊断与治疗,2015,(9):1979-1980.
|
[10] |
周焕娣,杨林,李苗,等.间苯三酚配合自由体位处理产程中宫颈水肿患者临床疗效观察[J].中国现代药物应用,2017,11(11):27-29.
|
[11] |
张娟,王绪丽.利多卡因联合阿托品与地西泮治疗分娩时宫颈水肿的临床疗效比较[J].实用医药杂志,2014,31(7):619.
|
[12] |
吕连英,陈世新,黄秀兰.地西泮加低浓度催产素用于治疗宫颈水肿的疗效观察[J].山西医药杂志,2014,43(9):1034-1035.
|
[13] |
闫琼琼.间苯三酚联合地西泮在产程中的应用效果研究[J].临床医学研究与实践,2017,2(35):111-112.
|
[14] |
智慧,魏梅,杨利.硫酸镁注射液局部外敷对宫颈水肿治疗的效果及对产妇产程及新生儿结局的影响[J].健康大视野,2019,(24):125.
|
[15] |
王敏.间苯三酚注射液对产程活跃期宫颈水肿产妇的临床效果分析[J].心理月刊,2019,14(2):114-115.
|
[16] |
曾婷蓉.山莨菪碱与利多卡因在产程活跃期宫颈水肿产妇中的疗效对比[J].海峡药学,2019,31(6):121-123.
|
[17] |
杨坤,王勇,唐萍,等.间苯三酚、利多卡因联合徒手扩张推举宫颈法治疗产程活跃期宫颈水肿的效果观察[J].南昌大学学报(医学版),2010,50(4):80-82,87.
|
[18] |
李静.盐酸利多卡因配伍盐酸消旋山莨菪碱在人流术中的应用[J].世界最新医学信息文摘(连续型电子期刊),2015,(42):81.
|
[19] |
戴巍.盐酸山莨菪碱注射液联合低位小水囊用于足月妊娠引产的临床效果分析[J].实用临床医药杂志,2014,18(21):206-208.
|
[20] |
李秀玲,肖红.盐酸哌替啶配伍山莨菪碱对加速产程进展的临床观察[J].护士进修杂志,2013,28(7):604-605.
|
|
|
|